Clinical Trials List
2022-04-01 - 2028-02-28
Phase III
Recruiting5
ICD-10C18.8
Malignant neoplasm of overlapping sites of colon
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.8
Malignant neoplasm of other specified sites of large intestine
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Jen-Shi Chen Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Wen-Chi Chou 無
- 黃文冠 無
- Mengting Peng 無
- 張境夫 無
- 余紹銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Peng-Chan Lin Division of Hematology & Oncology
- Shang-Hung Chen 國家衛生研究院
- 陳柏全 Division of General Surgery
- 黃盈慈 Division of Hematology & Oncology
- Yung-Yeh Su 國家衛生研究院
- Jui-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ann-Lii Cheng 無
- Chih-Hung Hsu 無
- 林宗哲 無
- Chiun Hsu 無
- Ying-Chun Shen 無
- 張端瑩 無
- YU-YUN SHAO 無
- 呂理駿 無
- JHE-CYUAN GUO 無
- 陳國興 無
- 梁逸歆 無
- 黃柏翔 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Chueh-Chuan Yen
- Ming-Huang Chen Division of Hematology & Oncology
- Chien-An Liu Division of Radiation Therapy
- Yi-Ping Hung Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
400 participants
